STI-571 in the treatment of CML: A perspective on this new agent, and its potential future utility

This article has been archived.
Please use for reference only.

Bradley Somer, MD
University of Pennsylvania Cancer Center
Ultima Vez Modificado: 1 de noviembre del 2001

Translation for this article does not exist

Frequently Asked Questions